Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
31 Jan 2024
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,734,778
-1%
57,499
$32.35
$1,860,019.20
SELL
12 Jan 2024
Hamilton James C
Chief Discovery/Trans Medicine, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
214,553
-3%
7,940
$36.89
$292,903.60
SELL
11 Jan 2024
Waddill William D.
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
49,170
-7%
3,934
$38.07
$149,758.55
SELL
11 Jan 2024
Ferrari Mauro
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
61,778
-4%
3,147
$38.06
$119,786.60
SELL
11 Jan 2024
Vakiener Victoria
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
33,101
-12%
4,720
$38.10
$179,813.39
SELL
11 Jan 2024
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
130,811
-2%
2,911
$38.06
$110,788.36
SELL
4 Jan 2024
San Martin Javier
Chief Medical Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
206,000
-3%
8,303
$35.26
$292,803.94
SELL
4 Jan 2024
Oliver Tracie
Chief Commercial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
136,501
-0%
74
$33.89
$2,507.86
SELL
4 Jan 2024
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
455,304
-3%
16,104
$35.27
$567,909.60
SELL
3 Jan 2024
O'Brien Patrick
COO and General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
485,326
-6%
33,190
$34.36
$1,140,362.40
SELL
3 Jan 2024
Hamilton James C
Chief Discovery/Trans Medicine
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
249,134
-13%
38,443
$34.69
$1,333,529.00
SELL
2 Jan 2024
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,720,366
-0%
9,952
$31.01
$308,636.66
SELL
20 Dec 2023
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,725,000
-0%
12,000
$28.54
$342,480.00
SELL
25 Oct 2023
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,737,000
-0%
24,338
$24.21
$589,222.94
SELL
18 Sep 2023
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,787,570
-1%
57,755
$28.12
$1,624,222.60
SELL
3 Jul 2023
Oliver Tracie
Chief Commercial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
61,575
-12%
8,925
$35.31
$315,141.75
SELL
30 Jun 2023
Hamilton James C
Chief Discovery/Trans Medicine
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
188,484
-1%
3,000
$35.53
$106,590.00
SELL
27 Jun 2023
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
381,704
-3%
15,000
$36.20
$543,000.00
SELL
5 May 2023
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
117,635
-5%
6,500
$40.90
$265,850.00
SELL
3 May 2023
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,787,330
-2%
104,928
$39.32
$4,125,673.50
SELL
3 Mar 2023
OLUKOTUN ADEOYE Y
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
7,867
-59%
11,350
$32.65
$370,577.53
SELL
27 Feb 2023
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
13,000
-6%
875
$32.62
$28,542.50
SELL
31 Jan 2023
Daniel Goldman
Congressman (House)
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
N/A
N/A
N/A
$1,001 - $15,000
SELL
9 Jan 2023
Waddill William D.
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
28,950
-9%
3,200
$30.00
$96,000.00
SELL
5 Jan 2023
Hamilton James C
Chief Discovery/Trans Medicine
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
198,057
-6%
13,803
$37.40
$516,232.20
SELL
5 Jan 2023
O'Brien Patrick
COO and General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
420,875
-3%
15,000
$37.39
$560,850.00
SELL
3 Jan 2023
Hamilton James C
Chief Discovery/Trans Medicine
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
154,431
-6%
10,338
$38.38
$396,737.94
SELL
3 Jan 2023
O'Brien Patrick
COO and General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
378,222
-4%
17,500
$38.33
$670,802.20
SELL
29 Dec 2022
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
336,704
-8%
30,625
$40.00
$1,225,000.00
SELL
21 Nov 2022
San Martin Javier
Chief Medical Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
91,700
-17%
19,500
$29.99
$584,738.00
SELL
11 Feb 2022
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
4,163,169
-3%
146,388
$51.91
$7,598,864.50
SELL
5 Jan 2022
O'Brien Patrick
General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
368,941
-8%
32,500
$61.72
$2,005,875.40
SELL
5 Jan 2022
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
488,097
-7%
40,000
$61.70
$2,467,941.00
SELL
4 Jan 2022
Hamilton James C
Senior Vice President
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
159,585
-13%
25,625
$64.57
$1,654,591.10
SELL
3 Jan 2022
Waddill William D.
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
28,150
-13%
4,500
$64.72
$291,244.28
SELL
3 Jan 2022
OLUKOTUN ADEOYE Y
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
7,110
-36%
4,050
$64.75
$262,233.06
SELL
3 Jan 2022
De Backer Marianne
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
19,256
-18%
4,500
$64.71
$291,176.84
SELL
3 Jan 2022
PERRY MICHAEL S
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
87,372
-4%
4,500
$64.71
$291,192.40
BUY
28 Dec 2021
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
109,868
+0%
655
$66.37
$43,472.35
SELL
28 Dec 2021
Ferrari Mauro
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
36,571
-8%
3,400
$66.82
$227,188.00
SELL
15 Dec 2021
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,253,165
-1%
60,000
$67.56
$4,053,431.50
SELL
19 Nov 2021
San Martin Javier
Chief Medical Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
116,796
-14%
19,500
$69.31
$1,351,589.00
SELL
20 Oct 2021
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
3,284,852
-1%
65,000
$65.77
$4,274,981.50
SELL
13 Sep 2021
OLUKOTUN ADEOYE Y
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
11,750
-29%
5,000
$63.76
$318,800.00
SELL
9 Sep 2021
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
109,868
-4%
5,000
$65.24
$326,200.00
SELL
24 Jun 2021
De Backer Marianne
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
21,500
-18%
5,000
$89.85
$449,250.00
SELL
22 Jun 2021
Hassard James
Chief Commercial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
105,750
-3%
3,625
$89.22
$323,422.50
SELL
22 Jun 2021
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
114,868
-3%
4,500
$89.21
$401,445.00
SELL
22 Feb 2021
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
13,875
-7%
1,125
$88.73
$99,821.25
SELL
8 Feb 2021
O'Brien Patrick
General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
375,414
-19%
90,000
$88.46
$7,961,240.50
SELL
15 Jan 2021
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
12,500
-19%
3,000
$83.28
$249,840.00
SELL
14 Jan 2021
Hamilton James C
Senior Vice President
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
130,064
-7%
10,000
$81.29
$812,941.90
SELL
11 Jan 2021
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
444,005
-2%
13,038
$81.02
$1,056,309.90
SELL
7 Jan 2021
Hassard James
Chief Commercial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
109,375
-12%
15,625
$75.00
$1,171,875.00
SELL
6 Jan 2021
O'Brien Patrick
General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
317,233
-7%
25,000
$72.41
$1,810,345.50
SELL
6 Jan 2021
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
486,568
-5%
30,625
$72.44
$2,218,477.00
SELL
5 Jan 2021
Hamilton James C
Senior Vice President
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
154,925
-20%
38,750
$72.51
$2,809,578.50
SELL
1 Jan 2021
PERRY MICHAEL S
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
90,000
-4%
4,000
$76.09
$304,360.00
SELL
1 Jan 2021
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
119,368
-3%
4,000
$76.08
$304,320.00
SELL
1 Jan 2021
Waddill William D.
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
30,250
-11%
3,750
$76.08
$285,300.00
SELL
10 Dec 2020
Waddill William D.
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
26,800
-10%
3,000
$71.26
$213,780.00
SELL
8 Dec 2020
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,527,187
-2%
55,000
$68.73
$3,780,347.20
SELL
7 Dec 2020
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
114,738
-7%
9,575
$79.32
$759,442.50
SELL
19 Nov 2020
Bradshaw Curt
Chief Scientific Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
0
-100%
31,250
$69.06
$2,158,125.00
SELL
19 Nov 2020
San Martin Javier
Chief Medical Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
130,500
-13%
19,500
$69.39
$1,353,105.00
SELL
9 Nov 2020
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
445,333
-8%
43,505
$69.37
$3,018,070.50
SELL
23 Oct 2020
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,517,509
-3%
100,000
$58.21
$5,821,031.50
SELL
20 Oct 2020
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
427,668
-6%
29,166
$54.04
$1,576,130.60
SELL
9 Oct 2020
Ferrari Mauro
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
30,971
-24%
10,000
$48.00
$480,000.00
BUY
8 Oct 2020
De Backer Marianne
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
17,000
+6%
1,000
$50.47
$50,465.00
SELL
13 Aug 2020
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,605,237
-1%
50,000
$41.35
$2,067,499.90
SELL
25 Jun 2020
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,605,260
-3%
100,000
$38.81
$3,881,017.20
SELL
12 May 2020
PERRY MICHAEL S
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
14,100
-71%
36,000
$35.83
$1,289,891.00
SELL
11 May 2020
Waddill William D.
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
28,000
-48%
26,000
$36.54
$950,040.00
SELL
27 Apr 2020
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
855,331
-0%
5,401
$40.00
$216,040.00
SELL
20 Apr 2020
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
871,449
-2%
23,515
$40.00
$940,600.00
SELL
14 Apr 2020
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
155,925
-13%
25,000
$36.89
$922,250.00
SELL
21 Jan 2020
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
418,139
-8%
40,313
$49.44
$1,992,924.50
BUY
13 Jan 2020
De Backer Marianne
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
16,500
+32%
4,000
$33.56
$134,240.00
SELL
6 Jan 2020
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
882,759
-3%
35,613
$60.13
$2,141,285.20
SELL
6 Jan 2020
O'Brien Patrick
General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
267,406
-5%
14,625
$60.12
$879,260.60
SELL
6 Jan 2020
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
403,592
-4%
20,000
$60.11
$1,202,200.60
SELL
24 Dec 2019
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,805,237
-4%
83,333
$63.50
$5,291,645.50
SELL
12 Dec 2019
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,962,952
-8%
183,333
$67.15
$12,310,120.00
SELL
2 Dec 2019
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,079,925
-2%
50,000
$67.33
$3,366,521.80
SELL
1 Nov 2019
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
330,156
-10%
37,884
$40.85
$1,547,378.00
SELL
10 Oct 2019
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,121,903
-2%
56,325
$31.83
$1,792,824.80
SELL
25 Sep 2019
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,121,903
-0%
20,000
$28.25
$565,000.00
SELL
20 Sep 2019
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,154,576
-4%
112,650
$28.54
$3,215,055.20
SELL
9 Sep 2019
PERRY MICHAEL S
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
36,000
-83%
185,000
$29.41
$5,440,000.00
SELL
26 Jun 2019
Ferrari Mauro
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,900
-90%
17,756
$27.61
$490,243.16
SELL
28 May 2019
O'Brien Patrick
General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
203,000
-12%
30,000
$24.88
$746,400.00
SELL
21 May 2019
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
278,536
-8%
27,071
$22.00
$595,562.00
SELL
3 Apr 2019
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
2,092,455
-2%
50,000
$19.30
$964,999.94
SELL
1 Mar 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
644,606
-6%
42,500
$19.99
$849,575.00
SELL
25 Feb 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
644,606
-6%
42,500
$18.98
$806,650.00
SELL
22 Feb 2019
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
175,130
-27%
68,000
$19.20
$1,305,400.00
SELL
19 Feb 2019
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
305,607
-2%
8,000
$18.00
$144,000.00
SELL
15 Feb 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
644,606
-9%
68,750
$17.86
$1,227,987.50
SELL
8 Feb 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
670,856
-26%
242,834
$16.04
$3,894,247.00
SELL
5 Feb 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
847,856
-2%
22,500
$14.48
$325,800.00
SELL
1 Feb 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
870,356
-3%
28,500
$13.85
$394,725.00
SELL
22 Jan 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
898,856
-15%
169,500
$13.54
$2,295,805.00
SELL
22 Jan 2019
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
178,130
-1%
3,000
$13.58
$40,740.00
SELL
18 Jan 2019
O'Brien Patrick
General Counsel, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
233,000
-23%
72,000
$14.43
$1,038,960.00
SELL
17 Jan 2019
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
305,607
-21%
81,875
$14.55
$1,191,281.20
SELL
14 Jan 2019
Li Zhen
Snr. VP, Chem and Non-Clin Dev, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
201,700
-16%
40,500
$14.34
$580,770.00
SELL
14 Jan 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,068,356
-3%
42,666
$14.40
$614,390.40
SELL
11 Jan 2019
Waddill William D.
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
46,500
-15%
8,500
$14.77
$125,545.00
SELL
1 Jan 2019
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
387,482
-2%
8,333
$11.98
$99,829.34
SELL
1 Jan 2019
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,098,356
-1%
20,000
$11.98
$239,599.98
SELL
27 Dec 2018
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
145,130
-2%
3,000
$12.00
$36,000.00
SELL
19 Dec 2018
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,542,455
-5%
90,000
$13.92
$1,252,800.00
SELL
12 Dec 2018
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,632,455
-5%
90,000
$14.07
$1,266,300.00
SELL
23 Nov 2018
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
148,130
-1%
3,000
$12.74
$38,220.00
SELL
9 Nov 2018
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,727,755
-4%
81,500
$14.39
$1,172,705.00
SELL
19 Oct 2018
Leone Peter Brian
VP, Strategic Bus. Initiatives, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
130,000
-50%
131,137
$13.49
$1,769,038.10
SELL
6 Sep 2018
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
330,815
-11%
45,000
$19.34
$870,200.00
SELL
31 Aug 2018
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,803,955
-8%
164,834
$14.45
$2,381,851.20
SELL
19 Jun 2018
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
310,815
-6%
20,000
$14.01
$280,200.00
SELL
30 May 2018
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
310,815
-4%
14,000
$11.00
$154,000.00
SELL
24 Apr 2018
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
155,000
-13%
25,000
$6.63
$165,750.00
SELL
27 Mar 2018
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
310,815
-6%
20,000
$8.00
$160,000.00
SELL
16 Mar 2018
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,968,789
-1%
26,000
$7.40
$192,400.00
SELL
13 Mar 2018
Anzalone Christopher Richard
Chief Executive Officer, Director, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
1,994,789
-13%
300,000
$7.43
$2,228,000.00
SELL
5 Mar 2018
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
908,356
-2%
20,000
$6.73
$134,600.00
SELL
1 Jan 2018
GIVEN BRUCE D
Chief Operating Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
928,356
-2%
20,000
$3.69
$73,800.00
SELL
22 Aug 2016
Myszkowski Kenneth Allen
Chief Financial Officer, Officer
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
115,689
-14%
20,000
$8.00
$160,000.00
SELL
12 Jan 2016
GIVEN DOUGLAS B
Director
ARROWHEAD PHARMACEUTICALS, INC.
(ARWR)
70,000
-14%
12,000
$6.72
$80,640.00
Home